Monday, May 12, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

941 POSTS 0 COMMENTS
Superbug News - CoronaVirus Watch List

CoronaVirus Watch List Stocks in the News (Bloomberg, Benzinga).

Editor / Curator -
Immunomedics, Biotech Stock Review
All News

Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in...

Editor / Curator -
Citius Pharmaceutical, CTXR, Biotech Stock Review
Biotech News

New Report: Citius Pharma (CTXR) Now Our #1 Ranked Idea for...

Editor / Curator -
Biotech News

Citius Pharma (CTXR) Corporate Presentation (Jan 2020).

Editor / Curator -
Oramed, Biotech Stock REview
Biotech News

Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?

Editor / Curator -
Mitesco, Biotech Stock Review
Incubator

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter...

Editor / Curator -
IPOS

Going Public. Direct Listing Update, (Anthony L.G., PLLC)

Editor / Curator -
Uncategorized

Going Public Guide (PWC).

Editor / Curator -
Biotech News

Hapbee Corporate Presentation. Private.

Editor / Curator -
video
Biotech News

Candida Auris: Hospitals mobilize to fight the deadly infection (Video). More...

Editor / Curator -
1...747576...95Page 75 of 95

Latest article

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.